Share this site with others using one of these sharing tools.
To link to this article, paste this block of HTML code onto your webpage.
Guidelines for sites linking to mayoclinic.orgThe Leukemia/Myelodysplasia Group at Mayo Clinic includes basic scientists and hematologists whose goal is to improve the outlook for patients with leukemia. Their research focuses on investigating the disease's biology, identifying risk factors, developing new drugs, detecting familial traits and studying the disease's epidemiology. Mayo Clinic experts conduct research trials and participate in national studies that test new treatments. Other research focuses on improving blood and marrow transplant and immunologic therapy for acute leukemia.
Investigational chemotherapy drugs such as Compound 506U78 (ARA-G) are available to patients through clinical trials. Another trial compares the benefits and risks of transplant versus chemotherapy.
See a list of publications on acute leukemia by Mayo Clinic authors on PubMed, a service of the National Library of Medicine.
To find out more about related research, visit the Hematology Research Web page.
Researchers conducting research on leukemia:
.
Find Mayo Clinic on